Global Endocrinology/Metabolics Market Research Reports - Data on Endocrinology/Metabolics in Global page 1

Printer Format

Region:	All Regions > Global
Category:	All Categories > Life Sciences > Pharmaceuticals > Therapeutic Area > Endocrinology/Metabolics

(30 reports matching your criteria)

Competing in the Global Endocrine Functions Diagnostics Market: Emerging Tests, Technology Assessment, Instrumentation Review, Market Shares, Sales Forecasts, and Strategic Profiles of Key Players 2/26/2013 \| published by: Venture Planning Group ... of leading suppliers. During the next decade, the endocrine function testing market will undergo significant transformation. These changes will be caused by convergence of new and more stringent regulations; advances in diagnostic technologies, system engineering, ... \| read more...	$8,500.00
Global Endocrinology Drugs Market 2012-2016 1/16/2013 \| published by: Infiniti Research Limited ... drugs. The Global Endocrinology Drugs market has also been witnessing the increase in market consolidation. However, the off-label use of the human growth hormone could pose a challenge to the growth of this market. TechNavio's ... \| read more...	$2,000.00
The 2013-2018 World Outlook for Pharmaceuticals Affecting Neoplasms, the Endocrine System, and Metabolic Diseases 1/7/2013 \| published by: Icon Group International, Inc. ... than 200 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is ... \| read more...	$795.00
The 2013-2018 World Outlook for Pharmaceutical Preparations for Human Use Affecting Neoplasms, the Endocrine System, and Metabolic Diseases 1/7/2013 \| published by: Icon Group International, Inc. ... the endocrine system, and metabolic diseases across more than 200 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of ... \| read more...	$795.00
The 2013 World Market Forecasts for Imported Natural or Synthetic Hormones, Hormone Derivatives, and Other Steriods Used as Hormones Excluding Medicaments 1/4/2013 \| published by: Icon Group International, Inc. ... With the globalization of this market, managers can no longer be contented with a local view. Nor can managers be contented with out-of-date statistics that appear several years after the fact. I have developed a ... \| read more...	$325.00
The World Market for Medicaments Containing Adrenal Cortical Hormones in Measured Doses or in Forms or Packings for Retail Sale: A 2013 Global Trade Perspective 1/1/2013 \| published by: Icon Group International, Inc. ... With the globalization of this market, managers can no longer be contented with a local view. Nor can managers be contented with out-of-date statistics that appear several years after the fact. I have developed a ... \| read more...	$595.00
The World Market for Natural or Synthetic Hormones, Hormone Derivatives, and Other Steriods Used as Hormones Excluding Medicaments: A 2013 Global Trade Perspective 1/1/2013 \| published by: Icon Group International, Inc. ... globalization of this market, managers can no longer be contented with a local view. Nor can managers be contented with out-of-date statistics that appear several years after the fact. I have developed a methodology, based ... \| read more...	$595.00
The World Market for Medicaments Containing Hormones, Their Derivatives, and Other Steriods Used as Hormones Excluding Antibiotics and Their Derivatives: A 2013 Global Trade Perspective 1/1/2013 \| published by: Icon Group International, Inc. ... With the globalization of this market, managers can no longer be contented with a local view. Nor can managers be contented with out-of-date statistics that appear several years after the fact. I have developed a ... \| read more...	$595.00
Global Metabolomics Market 2012-2016 12/14/2012 \| published by: Infiniti Research Limited ... activities. The Global Metabolomics market has also been witnessing the emergence of coordination of standards in metabolomics. However, the low adoption of metabolomics technology, especially among large pharmaceutical companies could pose a challenge to the ... \| read more...	$2,000.00
Global Human Growth Hormone Market Report: 2012 Edition 10/1/2012 \| published by: Koncept Analytics ... hormones. It is a pea sized gland situated at the base of brain and is a major component of human body as it expedites the response towards the surrounding environment and settings. Any deformity or ... \| read more...	$800.00
Future Horizons in the Global Endocrine Function Diagnostics Market: US, Europe, Japan Test Volume and Sales Forecasts by Country and Market Segment 8/30/2012 \| published by: Venture Planning Group ... and intensifying competition. Some segments will start resembling commodity markets, where product positioning and cost per test are more critical than underlying technology. This evolving marketplace will create exciting opportunities for a variety of new ... \| read more...	$7,500.00
Human Growth Hormone Drugs 8/1/2012 \| published by: Global Industry Analysts ... for the period 2009 through 2018. Also, a six-year historic analysis is provided for these markets. The report profiles 37 companies including many key and niche players such as Eli Lilly and Company, Ferring Pharmaceuticals ... \| read more...	$4,200.00
Global Breast Cancer Drugs Market 2011-2015 7/19/2012 \| published by: Infiniti Research Limited ... of breast cancer worldwide. The Global Breast Cancer Drugs market has also been witnessing the trend of the emergence of combination therapies to treat breast cancer effectively. However, the availability of alternative treatment methods could ... \| read more...	$1,500.00
Other Metabolic Disorders Global Clinical Trials Review, H1, 2012 6/30/2012 \| published by: GlobalData ... provides elemental information and data relating to the clinical trials on Other Metabolic Disorders. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the ... \| read more...	$2,500.00
Growth Hormone Deficiency Global Clinical Trials Review, H1, 2012 4/30/2012 \| published by: GlobalData ... provides elemental information and data relating to the clinical trials on Growth Hormone Deficiency. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the ... \| read more...	$1,000.00
2012 Global Endocrine Function Testing Market Outlook: Growth Opportunities and Strategies 4/18/2012 \| published by: Venture Planning Group ... and intensifying competition. Some segments will start resembling commodity markets, where product positioning and cost per test are more critical than underlying technology. This evolving marketplace will create exciting opportunities for a variety of new ... \| read more...	$7,500.00
Global Human Growth Hormone Drugs Market 2011-2015 4/16/2012 \| published by: Infiniti Research Limited ... in number of people suffering from growth hormone deficiency. The Global Human Growth Hormone Drug market has also been witnessing the use of human growth hormone for anti-ageing remedy. However, the reluctance of physicians to ... \| read more...	$1,500.00
Testosterone Replacement Therapy (TRT) 3/1/2012 \| published by: Global Industry Analysts ... separate comprehensive analytics for the US, Canada, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2009 through 2017. Also, a six-year historic analysis is provided for ... \| read more...	$4,600.00
Hormone Replacement Therapy (HRT) 9/1/2011 \| published by: Global Industry Analysts ... provided for the period 2009 through 2017. A six-year historic analysis is also provided for these markets. The report profiles 42 companies including many key and niche players such as Bayer HealthCare Pharmaceuticals, Inc., Besins ... \| read more...	$4,200.00
Growth Hormone Deficiency Global Clinical Trials Review, Q2, 2011 6/24/2011 \| published by: GlobalData ... provides elemental information and data relating to the clinical trials on Growth Hormone Deficiency. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the ... \| read more...	$1,000.00
Global Market for Hormonal Contraceptives and Infertility Drugs, 2011-2018 - Future Therapies for Birth Control and Reproductive Health 5/25/2011 \| published by: Spectra Intelligence ... Contraceptives and Infertility Drugs, 2011-2018 - Future Therapies for Birth Control and Reproductive Health (2nd Edition) the reader will be introduced to an analysis of current product markets, research and development themes, and company activities ... \| read more...	$2,815.00
Testosterone Replacement Therapy (TRT) 4/1/2011 \| published by: Global Industry Analysts ... separate comprehensive analytics for the US, Canada, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2009 through 2017. Also, a six-year historic analysis is provided for ... \| read more...	$4,600.00
The World Market for Diabetes Treatments 10/1/2010 \| published by: Kalorama Information ... pharmaceutical sector, and is one of the few pharmaceutical sectors that are likely to continue to grow at double digit rates throughout the forecast period. Major contributing factors to growth are increasing obesity and an ... \| read more...	$995.00
The World Market for Pituitary (Anterior) or Similar Hormones and Derivatives: A 2011 Global Trade Perspective 5/13/2010 \| published by: Icon Group International, Inc. ... longer be contented with a local view. Nor can managers be contented with out-of-date statistics that appear several years after the fact. I have developed a methodology, based on macroeconomic and trade models, to estimate ... \| read more...	$595.00
The World Market for Medicaments Containing Hormones 1/23/2009 \| published by: Icon Group International, Inc. ... With the globalization of this market, managers can no longer be contented with a local view. Nor can managers be contented with out-of-date statistics that appear several years after the fact. I have developed a ... \| read more...	$595.00

< prev 1 2 next >